Powder: -20°C for 3 years | In solvent: -80°C for 1 year
GW 441756 is a specific Tropomyosin-related kinase A (TrkA) inhibitor with an IC50 value of 2 nM.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 51.00 | |
10 mg | In stock | $ 80.00 | |
25 mg | In stock | $ 155.00 | |
50 mg | In stock | $ 237.00 | |
100 mg | In stock | $ 359.00 | |
500 mg | In stock | $ 849.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 57.00 |
Description | GW 441756 is a specific Tropomyosin-related kinase A (TrkA) inhibitor with an IC50 value of 2 nM. |
Targets&IC50 | TrkA:2 nM |
In vivo | GW441756 inhibits γH2AX production mediated by TrkA and apoptosis in cells overexpressing TrkA. It specifically blocks TrkA-induced cell death in a dose-dependent manner. |
Molecular Weight | 275.3 |
Formula | C17H13N3O |
CAS No. | 504433-23-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 4.1 mg/mL (15 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
GW 441756 504433-23-2 Apoptosis Cell Cycle/Checkpoint MAPK Tyrosine Kinase/Adaptors Trk receptor CDK Raf specific growth nerve potent inhibit Tropomyosin related kinase receptor Inhibitor tyrosine Trk Receptor NGF GW441756 receptor GW-441756 factor kinases inhibitor